MBTCNocturne Acquisition Corp

Nasdaq nocturnecorp.com


$ 11.95 $ -0.06 (-0.49 %)    

Friday, 22-Mar-2024 12:25:41 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 11.66
$ 11.95
$ 0.00 x 0
$ 11.03 x 100
$ 11.95 - $ 11.95
$ 9.45 - $ 13.98
141,136
na
60.53M
$ 0.02
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-21-2023 06-30-2023 10-Q
2 06-23-2023 03-31-2023 10-Q
3 05-26-2023 12-31-2022 10-K
4 11-21-2022 09-30-2022 10-Q
5 08-20-2022 06-30-2022 10-Q
6 05-16-2022 03-31-2022 10-Q
7 03-31-2022 12-31-2021 10-K
8 11-18-2021 09-30-2021 10-Q
9 08-16-2021 06-30-2021 10-Q
10 06-23-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

 nocturne-acquisition-says-co-intends-to-approve-extension-of-date-by-which-co-must-consummate-initial-business-combination-by-one-month-to-jan-5-2024

- SEC Filing

 cognos-therapeutics-inc-to-become-publicly-listed-on-nasdaq-via-business-combination-with-nocturne-acquisition-corporation-the-transaction-contemplates-an-enterprise-value-for-cognos-of-120m

Cognos Therapeutics is a medical technology company focused on developing unique, radically advanced devices for the treatment ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION